Showing results (901-910 of 1,504) with videos related to
Sort By:
Pageof 151
Familial Cancer|November 2, 2004
A636P testing in Ashkenazi JewsJose G Guillem, Harvey G Moore, Crystal Palmer, et al.Familial Cancer|November 2, 2004
Familial pancreatic carcinoma in JewsHenry T Lynch, Carolyn A Deters, Jane F Lynch, et al.Familial Cancer|May 8, 2004
Cancer variation associated with the position of the mutation in the BRCA2 geneJan Lubinski, Catherine M Phelan, Parviz Ghadirian, et al.Familial Cancer|September 2, 2004
HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differencesJeremy R JassFamilial Cancer|September 2, 2004
Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testingRaffaele Palmirotta, Sabino Matera, Maria Cristina Curia, et al.Familial Cancer|October 24, 2009
An Ashkenazi founder mutation in the MSH6 gene leading to HNPCCYael Goldberg, Rinnat M Porat, Inbal Kedar, et al.Familial Cancer|December 8, 2009
Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2 yearsKarin M Landsbergen, Judith B Prins, Yvonne J L Kamm, et al.Familial Cancer|December 2, 2009
Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detectionJ J T van Harssel, C E P van Roozendaal, Y Detisch, et al.Familial Cancer|December 13, 2005
Mutational analysis of hMsh6 in Israeli HNPCC and HNPCC-like familiesShiri Dovrat, Arie Figer, Herma H Fidder, et al.Familial Cancer|December 13, 2005
Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening proceduresAnja Wagner, Ingrid van Kessel, Mieke G Kriege, et al.Pageof 151